Prevention of Hypertension at Intubation: A Controlled Study of Sublingual Nifedipine

Authors

  • Nirmal Kumar Gyawali Consultant Anesthesiologist, Western Hospital Nepalgunj, Nepal

Keywords:

Intubation, laryngoscopy, hypertension, Pharmacology of Nifedipine, sublingual

Abstract

Background: Hypertension and tachycardia-induced after laryngoscopy and intubation can be prevented by various methods like deep inhalation anesthesia, intravenous opioids, topical intravenous lidocaine, intravenous adrenergic blocking drugs and pretreatment with antihypertensive.

Methods: It is a randomized controlled double-blind prospective study of two groups consisting of 30 patients in each group. Group A was the control group and group B were Nifedipine group who were pretreated with Nifedipine. This study aimed to assess the effectiveness of pretreatment with nifedipine in the prevention of the hypertensive response to laryngoscopy and endotracheal intubation in normotensive patients undergoing elective surgery.

Result: Sublingual nifedipine was significantly effective in decreasing systolic and diastolic blood pressure produced by laryngoscopy and tracheal intubation, but its role in decreasing pulse rate was not significant.

Conclusion: Nifedipine is useful to prevent laryngoscopy and intubation induced hemodynamic response.

DOI: https://doi.org/10.46405/ejms.v2i1.33

Downloads

Download data is not yet available.
Abstract
165
PDF
93
EJMS

Downloads

Published

2020-03-11

How to Cite

Gyawali, N. K. (2020). Prevention of Hypertension at Intubation: A Controlled Study of Sublingual Nifedipine. Europasian Journal of Medical Sciences, 2(1), 37–40. Retrieved from https://nepjol.info/index.php/ejms/article/view/32771

Issue

Vol. 2 No. 1 (2020): EJMS | January - June Issue

Section

Original Articles

License

All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.

On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/